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Glucose tolerance abnormalities (GTA) in CF adults: a highly 
prevalent situaSon insight on potential mechanisms 
S. Pot vin 1"~, M. Costa 1, D. Poisson 1, Y. Bet tlaiaume 1"~, A. Jeanneret 9, A. Lavoie 9, J.L. 
Chiasson 1, R. Rabasa Lhoret 1; 
~Research Center arul 2CF clinic, CHUM, Montr dal, Canada 
Introduction: GTA [impaired glucose tolerance (IGT) and CFRD] in CF patients is 
the most frequent co morbidity and its prevalence increases with age. As l ife 
expectancy greatly increases over the last few decades, GTA has increased too. 
Screening of CF patients with an oral glucose test tolerance (OGTF) was 
implemented to establish prevalence of GTA and to provide some mechanistic 
explanations. The relat ive role of the two major mechanisms for diabetes 
occurrence (insulin secretion defect and insulin resistance) are highly debated ha 
CFRD. 
Metbods: Ongoing study, CF patients without previous CFRD diaguosis and/or 
acute infection (stable cl inical state for 4 weeks), are requested to have an OGTF. 
Al l  tests were performed according to the standard recommendations. In order to 
evaluate insulin secretion mad insulin sensitivity, glucose mad insulin levels were 
meas'ared at baseline and 30, 60, 90, 120 minutes post glucose load. Results are 
presented on 69 out of the 175 identified patients in our institution. 
Results: 
Normal glucose tolerance (NGT) IGT CFRD 
N (%) 44 (63,8) 18(96,1) 7(10,1) 
Fasting glucose (rrtrno~L) 5,4 + 0,4 5,6 + 0,4 6,3 + 1,0" 
Stumvoll I 0,190+0,0")1 0,104+0,41 ~' 0,117+0,018 
hlsulin area under the curve z 4831 + 9366 5884 + 6297 3850 + 1597 
hazufin lreziztance and Zzecrefion i dex; *p < 0,01 compared to NGT and IGT; *p < 0,03 
compared to NGT 
Conclusion: GTA ha a CF population without previous CFRD diaguosis are frequent 
(36%). A l though insul in deficiency is bel ieved to be the cause of these 
physiopathological process, our data showed that insulin resistance is also present 
ha IGT and CFRD patients. Understanding glucose tolerance mechanisms wil l  have 
an impact on the global CF outcomes. 
311 
Serum Magnesium and Glucose Tolerance in Adults with CF 
E. Guma, A. Adler, C. Hawor th, D. Bi lton 
Adult CF Centre, Papworth Hospital, Cambridge, UK 
Aims: Prospective studies have shown that low serum maguesium (Mg) increases 
the risk of type 2 diabetes. Adults with CF have a prevalence of diabetes far higher 
thma the general population. We tested the association between serum Mg and 
dysglycaemia n British adults with CF. 
Methods: Patients were identified through a CF clinic providing annual 75 g oral 
glucose tolerance tests (OGTF) to those without diabetes. Of  160 patients, we  
excluded 2 with incomplete data. We used ANOVA to test the difference ha Mg 
levels between 3 groups defined by WHO criteria as normal glucose tolermace 
(NGT), impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), mad 
diabetes. We evaluated the association between Mg and OGTF results among 
subjects without diabetes, and between Mg mad haemoglobin A lc  (HbAlc)  for 
those with diabetes. 
Results: O1" 158 patients, 83 patients had NGT, 24 IGT or IFG, mad 51 diabetes. The 
mema for age was 26 (16 58) years, for BMI  21 ( 1 (~28) kg/m 2, mad for Mg 0.82 (SD 
0.09) mmol/l.  The mema Mg differed between groups (p 0.002) with values of 
0.85, 0.81, and 0.79 mmol/ l  for NGT, IGT or IFG, mad diabetes respectively. In 
patients without diabetes, Mg was inversely associated with both fasting plasma 
glucose and the 2 hour plasma glucose (13 2.143, p 0.019 and 13 1.061, 
p~).019). These findings were not altered by adjustment for serum calcium, vitamin 
D levels, oral steroid use, days of IV matibiotic use in the previous year, pancreatin 
dose, or renal function estimated by Cockcrott Gault, none of which was associated 
with glucose levels. Among those with diabetes, we  found no association between 
Mg and HbAlc .  
Conclusions: In adults with CF, lower magnesium levels are associated with a 
higher r isk of diabetes, and with higher glucose levels in the absence of diabetes. 
Prospective studies wi l l  better define these findings. 
310 
Glucose tolerance status in relation to lung function and growth 
Z. Ibrahim, M. Dixon, J. Vyas, T.J. David, L. Patel 
Paediatric Cystic Fibrosis Service, Central Manchester arm Manchester Childrens 
University Hospitals 
Aims. To study (1) glucose tolerance (GT) status ha relation to lung function 
0aEVI%), nutritional status (weight sds) mad linear growth (height sds); (2) chmages 
ha growth in the year preceding the diaguosis of impaired GT (IGT) and CFRD mad 
(3) r isk factors for IGT/CFRD. 
Metbods. The 73 CF patients who had ma oral GT test in the preceding 18 months 
and 4 patients with CFRD diaguosed from fasting hyperglycaemia were studied. 
Clinical details at the t ime of the OGTg/diaguosis of CFRD and ha the preceding 
year were obtained from the medical notes. 
Results. Medima age at the t ime of diaguosis of GT status did not differ but FEV 1%, 
weight sds and height sds were lower ha patients with IGT mad CFRD thma ha those 
with normal GT: 
Normal GT IGT CFRD P 
No. (%) 44 (57) 17 (22) 16 (21) 
Median age (y) 13.9 y 14.8 y 14.5 y 0.2 
Median FEV1% 76% 58% 56% 0.003 
Mean weight zds 0.4 zds 1.0 zds 1.7 zds 0.009 
Mean height Ms 0.5 Ms 1.3 Ms 1.4 Ms 0.0"? 
Changes in these cl inical parameters in the preceding year did not differ 
significantly according to GT status. Patients who had a decl ine in weight and 
height >0.5 sds were not more l ikely to have a lower GT status (P 0.09 and 0.3). 
Gastrostomy feeds (P 0.03) and oral corticosteroid treatment (P~).02) were risk 
factors associated with IGT and CFRD. 
Conclusions. At diagnosis of IGT/CFRD, patients with CF aged 8 18 years at a 
tertiary centre had worse lung function, apoorer nutritional state and were shorter than 
patients with normal GT. However, poor weight gain and linear growth ha the 
preceding yeac were not predictive of IGT/CFRD in individual patients. Patients who 
have gastrosiomy feeds or who ace on oral corticosieroids are at greater isk of 
IGT/CFRD, and should have OGTF prior to and at regular intervals during treatment. 
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Microvascular complications in paSents with cystic fibrosis-related 
diabetes (CFRD) 
J.M.W. vma den Berg 1, A.M. Motion 4, S. Kok 9, H. Pij l  ~, S.P. Conway 4, H.GM.  
Hei jerman 1 
~Adult Cystic Fibrosis Center aruJ 2Dept of lnt Med, Haga Hospital, The Hague; 
3Dept of Endocrinology, Leiden University Medical Cente5 Leiden, The 
Netherlaruls; 4Regional Adult Cystic Fibrosis Unit, Leeds, UK 
Aims This study aimed to quantitatively mad qualitatively assess microvascular 
complications in CFRD, compared to diabetes mell itus type 1 (DM1). We 
hypothesized CURD patients are less exposed to r isk factors and therefore less prone 
to develop microvascular complications. 
Methods 79 patients with CFRD were matched with 79 patients with DM1 
according to sex, age, and duration of insulin therapy. The risk factors studied were: 
smoking, BMI, HbAlc ,  cholesterol, cholesterol/HDL ratio, mad diastolic mad 
systolic tension. Microvascular complications investigated were: retinopathy, 
peripheral neur apathy, nephropathy, and micr oalbuminuria. 
Results In CFRD patients BMI  (p<0.CCO1), smoking (p<0.CCO1), total cholesterol 
(p<0.0CO1), and HbA lc  (p~3.056) were lower or not present, compared to DM1 
patients. Cholesterol/HDL ratio and diastolic and systolic tension were similar ha 
both groups. 
The total number of complications was the same ha both groups (23 cases), ha the 
CFRD group the incidence of microalbuminuria (p 0.003) and the median 
albumin/creatinine ratio (p<0.CCO1) was higher, but retinopathy occurred more 
often ha DM1 patients (p 0.04). No difference was found for peripheral neuropathy 
and nephr apathy. 
Conclusions The kind, but not the number, of micr ovascular diabetic omplications, 
differed between CFRD patients and DM1 patients. Probably due to less exposure 
of CFRD patients to smoking, high body mass index, diastolic hypertension, high 
serum levels of HbAlc ,  and total cholesterol, they developed less retinopathy. The 
larger incidence of microalbuminuria is probably attributable to unidentif ied r isk 
factors. 
